Citation Impact
Citing Papers
Functional analysis of human and chimpanzee promoters
2005 StandoutNobel
Four-component protein nanocages designed by programmed symmetry breaking
2024 StandoutNatureNobel
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
1992 StandoutNatureNobel
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Molecular biology and genetics of prion diseases
1994 StandoutNobel
Transgenetic investigations of prion diseases of humans and animals
1993 StandoutNobel
Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
2012
Monocyte and macrophage heterogeneity
2005 Standout
The Tn Antigen—Structural Simplicity and Biological Complexity
2011
Functional Analyses of Transcription Factor Binding Sites that Differ between Present-Day and Archaic Humans
2015 StandoutNobel
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Plant–derived vaccine protects target animals against a viral disease
1997
Mutation of the Prion Protein in Libyan Jews with Creutzfeldt–Jakob Disease
1991 StandoutNobel
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Phenotypic Characterization of Monocyte Subpopulations in the Pig
2000
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
1990 StandoutNobel
The Evolution of Transcriptional Regulation in Eukaryotes
2003
Role of streptococcal IgG Fc receptor in tissue deposition of IgG in rabbits immunized with Streptococcus pyogenes
1992
Structure of Dengue Virus
2002 Standout
Virus‑like particles as a vaccine delivery system: Myths and facts
2008
Bacillus Calmette-Guérin vaccination using a microneedle patch
2011
NS1 Protein of Parvovirus B19 Interacts Directly with DNA Sequences of the p6 Promoter and with the Cellular Transcription Factors Sp1/Sp3
2002
Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose
2011
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial
2016
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Manifestations of the local gastric immune response in gnotobiotic piglets infected with Helicobacter pylori
1996
Phenotypic and functional heterogeneity of porcine blood monocytes and its relation with maturation
2004
Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction
2001
Role of the gut microbiota in nutrition and health
2018 Standout
Detection of broadly expressed neuronal genes in C. elegans
2006 StandoutNobel
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Paradoxical shortening of scrapie incubation times by expression of prion protein transgenes derived from long incubation period mice
1991 StandoutNobel
Microneedles for drug and vaccine delivery
2012 Standout
Analysis of linkage between scrapie incubation period and the prion protein gene in mice
1990
Characterization of the gut microbiota in leptin deficient obese mice – Correlation to inflammatory and diabetic parameters
2014
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Wnt signalling in stem cells and cancer
2005 StandoutNature
Parvovirus B19
2004 Standout
Mice devoid of PrP are resistant to scrapie
1993 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Immunological characterisation of plasminogen activators in the human vessel wall.
1983
Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.
1984
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Adding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron Micrographs
2000
Idiotypic Networks and Other Preconceived Ideas
1984 StandoutNobel
Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies.
1977
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.
1982
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Idiotypic Regulation in Immune Networks
1981
Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).
1987
Human Parvovirus B19
2002 Standout
Pancreatic and intestinal processing of proglucagon in man
1987
Parvovirus Family Conundrum: What Makes a Killer?
2015
The mechanism of in vitro clot lysis induced by vascular plasminogen activator
1984
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
2000
Introduction to the human gut microbiota
2017 Standout
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
1982
Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH
1982
Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.
1983
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
A simple model for the immune network.
1990 StandoutNobel
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Adding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron Micrographs
1999
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.
1982
Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells
1982
New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product
2018 StandoutNobel
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Recurrent idiotopes and internal images.
1982 StandoutNobel
Minute virus of mice transcriptional activator protein NS1 binds directly to the transactivation region of the viral P38 promoter in a strictly ATP-dependent manner
1995
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
1981
Binding of urokinase to plasma proteinase inhibitors
1980
WNT signaling modulates the diversification of hematopoietic cells
2000
Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells
1983
The secretion of plasminogen activators by human myeloid leukemic cells in vitro
1983
Clinical and Microbiological Evidence for Endemic Pharyngitis Among Adults Due to Group C Streptococci
1990
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
1988 Standout
Purification and characterization of human kidney plasminogen activator dissimilar to urokinase
1982
Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid
1981
Tumors: Wounds That Do Not Heal
1986 Standout
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters.
1992 StandoutNobel
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
2012 Standout
Molecular Biology of Prion Diseases
1991 StandoutScienceNobel
IDENTIFICATION OF CELLS WITH PANCREATIC‐TYPE AND GUT‐TYPE GLUCAGON IMMUNOREACTIVITY IN THE HUMAN COLON
1975
The Autonomously Replicating Parvoviruses of Vertebrates
1987
Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis
2002 Standout
Evidence that glicentin contains the entire sequence of glucagon
1980
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
1984 Standout
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
1993 StandoutScience
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Comparative electrophoretic analysis of human and porcine plasminogen activators in sds-polyacrylamide gels containing plasminogen and casein
1983
Spontaneous Neurodegeneration in Transgenic Mice with Mutant Prion Protein
1990 StandoutScienceNobel
Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex
1984
Ultrastructural identification of cells storing pancreatic-type glucagon in dog stomach
1976
Works of Bent Aasted being referenced
CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
2011
Summary of workshop findings for porcine T-lymphocyte antigens
1994
Infection with human H1N1 influenza virus affects the expression of sialic acids of metaplastic mucous cells in the ferret airways
2009
Analyses of monoclonal antibodies reacting with porcine CD3: results from the Second International Swine CD Workshop
1998
Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink
1994
Analysis of monoclonal antibodies reactive with the porcine CD4 antigen
1994
Summary of workshop findings for porcine adhesion molecule subgroup
1998
Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species
1998
Identification of monoclonal antibodies that cross-react with cytokines from different animal species
2002
Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity
2011
Analysis of mAb reactive with the porcine SWC1
1994
Analyses of mAb reactive with porcine CD8
1994
Structural and serological relationships among different antibodies from the same rabbit antiserum. II. The idiotypes of ten antibody components from an anti‐streptococcal serum
1976
Characterization of the Antibody Production in Rabbits Induced by Streptococcal Group A and C Carbohydrate Antigens
1974
Aleutian disease virus, a parvovirus, is proteolytically degraded during in vivo infection in mink
1984
Purification and characterization of human vascular plasminogen activator
1980
Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease
1998
Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system
1993
Occurrence of both urokinase and tissue plasminogen activator in human seminal plasma
1979
Characterization of the Antibody Production in Rabbits Induced by Streptococcal Group A and C Carbohydrate Antigens
1974
Mink with Aleutian Disease Have High‐Affinity Antiviral Antibodies
1984
cis-acting sequences in the Aleutian mink disease parvovirus late promoter important for transcription: comparison to the canine parvovirus and minute virus of mice
1993
Purification and characterization of the major nonstructural protein (NS-1) of Aleutian mink disease parvovirus
1995
Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink
1985
Detection of Antibodies in Human Sera to Streptococcal Groups A and C Carbohydrates by a Radioimmunoassay
1979
Immunochemical characterization of human plasminogen activators
1981
Comparison of promoter activity in Aleutian mink disease parvovirus, minute virus of mice, and canine parvovirus: possible role of weak promoters in the pathogenesis of Aleutian mink disease parvovirus infection
1993
Isolation and Characterization of Rabbit Antibodies Directed against Group a Allotypic Determinants
1976
Role of alveolar type II cells and of surfactant-associated protein C mRNA levels in the pathogenesis of respiratory distress in mink kits infected with Aleutian mink disease parvovirus
1994
Analysis of the Quantity of Antiviral Antibodies from Mink Infected with Different Aleutian Disease Virus Strains
1984
PRODUCTION AND EVALUATION OF GLUCAGON ANTIBODIES FOR RADIOIMMUNOASSAY
1974
Three-Dimensional Structure of Aleutian Mink Disease Parvovirus: Implications for Disease Pathogenicity
1999